Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
Genentech in 2009
|
| gptkbp:advocacy |
supports patient advocacy groups
|
| gptkbp:annual_report |
publishes detailed financial reports
|
| gptkbp:awards |
recognized for innovation in healthcare
|
| gptkbp:capital |
approximately 200 billion CHF (2021)
|
| gptkbp:ceo |
gptkb:Severin_Schwan
|
| gptkbp:clinical_trial |
conducts thousands annually
conducts extensive clinical research |
| gptkbp:collaboration |
works with healthcare professionals
|
| gptkbp:collaborations |
forms research partnerships with universities
|
| gptkbp:community_engagement |
supports local health initiatives
|
| gptkbp:community_health |
engages in global health initiatives
|
| gptkbp:conducts_research_on |
has a dedicated research team
|
| gptkbp:cultural_diversity |
committed to workplace diversity
|
| gptkbp:diagnosis |
develops diagnostic tests for various diseases
|
| gptkbp:drug_approvals |
receives numerous drug approvals from regulatory bodies
|
| gptkbp:employees |
around 100,000 (2020)
|
| gptkbp:financial_performance |
strong financial performance in recent years
|
| gptkbp:financial_support |
provides patient support programs
|
| gptkbp:focus |
personalized healthcare
|
| gptkbp:founded |
gptkb:1896
|
| gptkbp:founder |
gptkb:Fritz_Hoffmann-La_Roche
|
| gptkbp:global_presence |
operates in over 100 countries
|
| gptkbp:headquarters |
gptkb:Basel,_Switzerland
|
| gptkbp:healthcare |
provides comprehensive healthcare solutions
|
| https://www.w3.org/2000/01/rdf-schema#label |
Roche Group
|
| gptkbp:industry |
gptkb:pharmaceuticals
|
| gptkbp:innovation |
focuses on innovative drug development
|
| gptkbp:invention |
holds numerous patents in pharmaceuticals
|
| gptkbp:investment |
invests in cutting-edge technology
|
| gptkbp:investment_strategy |
consistently performs well in stock market
|
| gptkbp:leadership |
female representation in leadership roles
|
| gptkbp:market_position |
one of the largest pharmaceutical companies globally
|
| gptkbp:marketing_strategy |
develops strategic marketing plans
|
| gptkbp:partnerships |
collaborations with academic institutions
alliances with biotech companies |
| gptkbp:products |
biopharmaceuticals
diagnostics |
| gptkbp:provides_guidance_on |
contributes to clinical guidelines in healthcare
|
| gptkbp:research_and_development |
over 10 billion CHF annually
|
| gptkbp:research_areas |
neurology
oncology infectious diseases immunology |
| gptkbp:revenue |
58.3 billion CHF (2020)
|
| gptkbp:social_responsibility |
focus on ethical business practices
|
| gptkbp:stock_exchange |
gptkb:SIX_Swiss_Exchange
|
| gptkbp:subsidiaries |
gptkb:Genentech
gptkb:Roche_Diagnostics |
| gptkbp:sustainability_initiatives |
environmental responsibility programs
access to healthcare programs |
| gptkbp:uses_technology |
pioneers in biotechnology solutions
|
| gptkbp:bfsParent |
gptkb:Genentech
|
| gptkbp:bfsLayer |
4
|